Artwork

Content provided by Stock Day Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stock Day Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Skinvisible Inc. | SFWJ DBA MedCana

0:54
 
Share
 

Manage episode 416992991 series 180440
Content provided by Stock Day Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stock Day Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Skinvisible, Inc. (OTCQB:SKVI) is excited to share a promising update on the ongoing clinical trials conducted by its licensee, Quoin Pharmaceuticals, Inc. (NASDAQ:QNRX). The trials focus on the innovative formulation “QRX003,” powered by Skinvisible’s Invisicare® proprietary drug delivery technology, to address the challenges of Netherton Syndrome (“NS”).
SFWJ DBA MedCana announces that Eko2o S.A.S, a Majority Controlled subsidiary of MedCana/SWJ in Colombia and a leading provider of greenhouse infrastructure and agricultural technology, proudly announces a significant partnership with Danziger Colombia. This strategic agreement, expected to generate between $2.5 million and $3 million in revenue over the next three years, marks a pivotal moment for both organizations in their commitment to innovative agricultural practices.
Eko2o will be providing greenhouse infrastructure services, irrigation products and technology as well as other technologies related to Danziger’s flower operations in Colombia.
For more information, visit StockDayMedia.com
  continue reading

1487 episodes

Artwork

Skinvisible Inc. | SFWJ DBA MedCana

Stock Day Media

61 subscribers

published

iconShare
 
Manage episode 416992991 series 180440
Content provided by Stock Day Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stock Day Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Skinvisible, Inc. (OTCQB:SKVI) is excited to share a promising update on the ongoing clinical trials conducted by its licensee, Quoin Pharmaceuticals, Inc. (NASDAQ:QNRX). The trials focus on the innovative formulation “QRX003,” powered by Skinvisible’s Invisicare® proprietary drug delivery technology, to address the challenges of Netherton Syndrome (“NS”).
SFWJ DBA MedCana announces that Eko2o S.A.S, a Majority Controlled subsidiary of MedCana/SWJ in Colombia and a leading provider of greenhouse infrastructure and agricultural technology, proudly announces a significant partnership with Danziger Colombia. This strategic agreement, expected to generate between $2.5 million and $3 million in revenue over the next three years, marks a pivotal moment for both organizations in their commitment to innovative agricultural practices.
Eko2o will be providing greenhouse infrastructure services, irrigation products and technology as well as other technologies related to Danziger’s flower operations in Colombia.
For more information, visit StockDayMedia.com
  continue reading

1487 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide